Switch to:
More From Other Websites
Vertex’s Cystic Fibrosis Drugs Drove Revenue Growth in 2Q16 Jul 29 2016
How Vertex’s Revenue and Earnings Surprised in 2Q16 Jul 29 2016
Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short Jul 28 2016
Edited Transcript of VRTX earnings conference call or presentation 27-Jul-16 8:30pm GMT Jul 28 2016
Nivalis (NVLS): Can the Stock Surprise This Earnings Season? Jul 27 2016
Vertex Pharmaceuticals reports 2Q loss Jul 27 2016
Vertex Pharmaceuticals reports 2Q loss Jul 27 2016
[$$] Vertex Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow Jul 27 2016
Vertex Reports Second Quarter 2016 Financial Results Jul 27 2016
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 27 2016
Vertex Reports Second Quarter 2016 Financial Results Jul 27 2016
Q2 2016 Vertex Pharmaceuticals Inc Earnings Release - After Market Close Jul 27 2016
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More Jul 26 2016
Understanding Improvement in Vertex Pharmaceuticals’s PE Multiple Jul 25 2016
Orkambi Launch Impacts Vertex Pharmaceuticals’s Major Revenue Contributor Jul 25 2016
Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store? Jul 25 2016
How Much Will Orkambi Fetch for Vertex Pharmaceuticals in 2Q16? Jul 22 2016
Is Vertex Pharmaceuticals Exposed to Drug Pricing Risks? Jul 22 2016
Wall Street Looks for Vertex Pharmaceuticals to Break Even in 2Q16 Jul 21 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK